Year |
Citation |
Score |
2021 |
Elrazaz EZ, Serya RAT, Ismail NSM, Albohy A, Abou El Ella DA, Abouzid KAM. Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorganic Chemistry. 113: 105019. PMID 34091286 DOI: 10.1016/j.bioorg.2021.105019 |
0.327 |
|
2015 |
Albohy A, Richards MR, Cairo CW. Mapping substrate interactions of the human membrane-associated neuraminidase, NEU3, using STD NMR. Glycobiology. 25: 284-93. PMID 25294388 DOI: 10.1093/Glycob/Cwu109 |
0.642 |
|
2014 |
Smutova V, Albohy A, Pan X, Korchagina E, Miyagi T, Bovin N, Cairo CW, Pshezhetsky AV. Structural basis for substrate specificity of mammalian neuraminidases. Plos One. 9: e106320. PMID 25222608 DOI: 10.1371/Journal.Pone.0106320 |
0.674 |
|
2013 |
Albohy A, Zhang Y, Smutova V, Pshezhetsky AV, Cairo CW. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4. Acs Medicinal Chemistry Letters. 4: 532-7. PMID 24900705 DOI: 10.1021/Ml400080T |
0.668 |
|
2013 |
Zhang Y, Albohy A, Zou Y, Smutova V, Pshezhetsky AV, Cairo CW. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues. Journal of Medicinal Chemistry. 56: 2948-58. PMID 23530623 DOI: 10.1021/Jm301892F |
0.654 |
|
2011 |
Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW. Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone. Biochemistry. 50: 6753-62. PMID 21675735 DOI: 10.1021/Bi200449J |
0.682 |
|
2011 |
Albohy A, Mohan S, Zheng RB, Pinto BM, Cairo CW. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Bioorganic & Medicinal Chemistry. 19: 2817-22. PMID 21489803 DOI: 10.1016/J.Bmc.2011.03.039 |
0.689 |
|
2010 |
Zou Y, Albohy A, Sandbhor M, Cairo CW. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid. Bioorganic & Medicinal Chemistry Letters. 20: 7529-33. PMID 21036040 DOI: 10.1016/J.Bmcl.2010.09.111 |
0.664 |
|
2010 |
Albohy A, Li MD, Zheng RB, Zou C, Cairo CW. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Glycobiology. 20: 1127-38. PMID 20511247 DOI: 10.1093/Glycob/Cwq077 |
0.689 |
|
2010 |
Cairo CW, Das R, Albohy A, Baca QJ, Pradhan D, Morrow JS, Coombs D, Golan DE. Dynamic regulation of CD45 lateral mobility by the spectrin-ankyrin cytoskeleton of T cells. The Journal of Biological Chemistry. 285: 11392-401. PMID 20164196 DOI: 10.1074/Jbc.M109.075648 |
0.513 |
|
2009 |
Ismail MAH, Lehmann J, Ella DAAE, Albohy A, Abouzid KAM. Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity Medicinal Chemistry Research. 18: 725-744. DOI: 10.1007/S00044-009-9163-2 |
0.395 |
|
Show low-probability matches. |